CMV retinitis: Difference between revisions
(→Source) |
|||
| Line 31: | Line 31: | ||
==Source== | ==Source== | ||
Tintinalli | Tintinalli | ||
UpToDate - "Pathogenesis, clinical manifestations, and diagnosis of AIDS-related cytomegalovirus retinitis" | |||
[[Category:ID]] | [[Category:ID]] | ||
[[Category:Ophtho]] | [[Category:Ophtho]] | ||
Revision as of 20:53, 11 March 2015
Background
- Most frequent and serious ocular OI
- Leading cause of blindness in AIDS pts
- Typically occurs with CD4 less than 50
Diagnosis
- Signs/symptoms are variable; may include:
- Change in visual acuity
- Visual field cuts (Scotomas, loss of central vision)
- Floaters, flashing lights
- Photophobia
- Eye redness/pain
Complications
- Retinal detachment
- Complete Vision loss
- CMV Immune Recovery Uveitis (IRU)
- Patients with retinitis who develop blurry vision after starting HART need ophtho eval to assess for CMV progression, relapse, or IRU
- Possible cause - T-cell mediated immune reconstitution to latent CMV intraocular antigens
- Symptoms - Floaters, photophobia, blurred vision
- Occurs median 20 weeks after starting HART
- Urgent ophtho eval
Treatment
- Ganciclovir implant and ganciclovir 1–1.5gm PO TID
See Also
Source
Tintinalli
UpToDate - "Pathogenesis, clinical manifestations, and diagnosis of AIDS-related cytomegalovirus retinitis"